Lichens are supposed to have nearly 600 unique chemicals. Usnic acid, one of them, is reported to possess a broad spectrum of pharmacological activities, related to its antioxidative properties. We characterized and screened different lichen extracts/fractions for their antioxidative, antimicrobial, and cytotoxic activity. The lichens Cladonia arbuscula (L.) Hoffm., Evernia prunastri (L.) Ac. and Usnea barbata (L.) Wigg. were collected in Mari El Republic of Russia (June 2011). Chloroform (CHCl3)-, hexane (Hex)-, dichloromethane (DCM) and acetonitrile (ACN) extracts were prepared and analysed by HPLC. As reference (+)-usnic acid was used. The total antioxidant activity was evaluated with phosphomolybdenum method. The total content of phenols was determined by Folin-Ciocalteau method. The antimicrobial activity was estimated by double microdilution method. Toxicity was evaluated (24 hrs) in human skin fibroblasts (HSKF) and in U-87 glioblastoma cells by resazurin assay. Phosphorylation of ERK1/2 was measured in U-87 cells by Western blot. The usnic acid content of the crude extracts (%) of C. arbuscula, E. prunastri and U. barbata were 8.91 ± 1.18, 5.68 ± 0.47, 74.49 ± 8.64 respectively. The tested antimicrobiobal activities (Staphylococcus aureus, Candida albicans, Escherichia coli, Pseudomonas aeruginosa, Mycobacterium tuberculosis) and the antioxidative capacity differed for the 3 extracts/fractions and were unrelated to the usnic acid content. In HSKFs the IC50 were 29.3 µg/mL, 78.6 µg/mL, 44.2 µg/mL and 15.5 µg/mL for the extracts of E. prunastri (DCM, ACN) and C. arbuscola (Hex, DCM) respectively. In U87 cells IC50 values ranged from 10.8 µg to 98.1 µg/mL. Phosphorylation of ERK1/2 was concentration dependently reduced. The tested pharmacological activities did not relate to the usnic acid content. The identification of further secondary metabolites with in depth investigations of different modes of action is required for drug development. Acknowledgement: A. Shcherbakova was supported by the DAAD.